RNA vaccine candidate (BioNTech SE)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RNA vaccine candidate (BioNTech SE), covering 2023-12-19 to 2023-12-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children [Phase 2, Phase 3]